POLYPEPTIDE LABORATORIES A/S: Financial statements 2017
CVR: 19056201
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
POLYPEPTIDE LABORATORIES A/S (CVR 19056201) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 721,000 and a net result of DKK -757,000 compared with DKK -3,321,000 the year before. That is a decrease of 95.3% compared with the year before. Equity in the 2017 report amounted to DKK 67,482,000. The solvency ratio was 99.8%.
- Gross Profit
- DKK 721,000
- Profit/Loss
- DKK -757,000
- Equity
- DKK 67,482,000
- Total Assets
- DKK 67,634,000
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 721 t. | -757 t. | 67.5 mio. | 0 |
| 2016 | - | 15.2 mio. | -3.3 mio. | 68.2 mio. | 12000 |
| 2015 | - | - | -9.5 mio. | 64.9 mio. | 31 |
| 2014 | - | 36.6 mio. | 17.1 mio. | 74.4 mio. | 26 |
| 2013 | - | 16.6 mio. | 4.9 mio. | 57.3 mio. | 31 |
Official annual report
Keep an eye on POLYPEPTIDE LABORATORIES A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
POLYPEPTIDE LABORATORIES A/S has published its annual report for 2016. Gross profit came to DKK 15,200,000, and the net result was DKK -3,321,000.
About POLYPEPTIDE LABORATORIES A/S
POLYPEPTIDE LABORATORIES A/S is a Danish company of the type Aktieselskab based in Hillerød, founded in 1996. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named A/S PSE NR. 4948. The management consists of Raoul Bernhardt. The board consists of Juan José Gonzalez Casanova (chair), Christina Ellen Del Vecchio and Raoul Bernhardt. The company is owned by PolyPeptide Laboratories Holding (PPL) AB. The company has 0 employees (2017). In 2025, the company reported a net result of DKK 2,632,000 compared with DKK 7,060,000 the year before. Equity in the 2025 report amounted to DKK 75,499,000.